+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point-of-Care Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis

  • ID: 5516108
  • Report
  • October 2021
  • Region: Global
  • 208 Pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2022

FEATURED COMPANIES

  • Abbott
  • binx health, Inc.
  • Biocartis
  • bioMérieux SA
  • Danaher Corporation
  • Enzo Biochem, Inc.
The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028. The growth of the market is primarily attributed to the growing demand for specific viral detection methods that consume less time for timely infection control and rising incidence of infectious diseases. Moreover, rising R&D and innovation in point-of-care molecular diagnostics are expected to foster the market growth during the forecast period. However, the pricing pressures owing to reimbursement cuts hinder the market growth. The COVID-19 pandemic has had a significant impact on the point-of-care molecular diagnostic market. Amid the pandemic, the increased demand for diagnostic kits for the rapid detection of COVID-19 boosted the adoption of point-of-care testing across the world. The rising number of COVID-19 cases and growing pressure on various governments across the world to improve patient management have boosted the demand for rapid antigen testing kits that can be effectively used in point-of-care settings.



Based on product & services, the point-of-care molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment leads the market and is expected to register the highest CAGR during the forecast period. Based on technology, the market is segmented into PCR, isothermal nucleic acid amplification technology (INAAT), and other technologies. The PCR segment leads the market, whereas the isothermal nucleic acid amplification technology (INAAT) segment is expected to register the highest CAGR during the forecast period. By application, the point-of-care molecular diagnostics market is segmented into infectious diseases, oncology, hematology, prenatal testing, endocrinology, and other applications. The infectious diseases segment holds the largest share of the market. However, the oncology segment is anticipated to register the highest CAGR in the market during the forecast period. By end user, the market is segmented into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others. The diagnostic laboratories segment leads the market and is estimated to register the highest CAGR in the market during the forecast period.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and International Agency for Research on Cancer are a few of the primary and secondary sources referred to while preparing the report on the point-of-care molecular diagnostics market.



Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the point-of-care molecular diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global point-of-care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • binx health, Inc.
  • Biocartis
  • bioMérieux SA
  • Danaher Corporation
  • Enzo Biochem, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Point-of-Care Molecular Diagnostics Market - By Product and Services
1.3.2 Global Point-of-Care Molecular Diagnostics Market - By Technology
1.3.3 Global Point-of-Care Molecular Diagnostics Market - By Application
1.3.4 Global Point-of-Care Molecular Diagnostics Market - By End User
1.3.5 Global Point-of-Care Molecular Diagnostics Market- By Geography

2. Global Point-of-Care Molecular Diagnostics Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Point-of-Care Molecular Diagnostics Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Experts Opinion

5. Point-of-Care Molecular Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis

6. Point-of-Care Molecular Diagnostics Market- Global Analysis
6.1 Global Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
6.2 Global Point-of-Care Molecular Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 - By Product and Services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product and Services 2021 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 - By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

9. Point-of-Care Molecular Diagnostics Market Analysis - By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 - By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11. Global Point-of-Care Molecular Diagnostics Market - Geographic Analysis
11.1 North America: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2 Europe: Point-of-Care Molecular Diagnostics Market
11.2.1 Overview
11.2.2 Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.2.4 Europe: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.2.5 Europe: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.2.6 Europe: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.2.7 Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.2.7.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.2 UK: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.1.3 UK: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.1.4 UK: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.1.5 UK: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.2 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.2 Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.2.3 Germany: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.2.4 Germany: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.2.5 Germany: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.3 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.2 France: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.3.3 France: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.3.4 France: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.3.5 France: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.4 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.2 Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.4.3 Italy: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.4.4 Italy: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.4.5 Italy: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.5 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.2 Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.5.3 Spain: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.5.4 Spain: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.5.5 Spain: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.6 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.2 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market
11.3.1 Overview
11.3.2 Asia Pacific: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.3.4 Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.3.5 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019-2028 (USD Million)
11.3.6 Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.3.7 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.3 China Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.4 China: Point-of-Care Molecular Diagnostics Market, by Application, 2019-2028 (USD Million)
11.3.7.1.5 China Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.2 Japan: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.3 Japan Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.4 Japan: Point-of-Care Molecular Diagnostics Market, by Application, 2019-2028 (USD Million)
11.3.7.2.5 Japan Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.3 India: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.3 India Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.4 India: Point-of-Care Molecular Diagnostics Market, by Application, 2019-2028 (USD Million)
11.3.7.3.5 India Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.4 Australia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 Australia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.3 Australia Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.4 Australia: Point-of-Care Molecular Diagnostics Market, by Application, 2019-2028 (USD Million)
11.3.7.4.5 Australia Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.5 South Korea: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 South Korea: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.3 South Korea Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.4 South Korea: Point-of-Care Molecular Diagnostics Market, by Application, 2019-2028 (USD Million)
11.3.7.5.5 South Korea Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.6 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.3 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.4 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019-2028 (USD Million)
11.3.7.6.5 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.4 Middle East & Africa: Point-of-Care Molecular Diagnostics Market
11.4.1 Overview
11.4.2 Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.4.4 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.4.5 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.4.6 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.4.7 Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.4.7.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.1.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.1.2 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.1.3 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.1.4 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.1.5 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.2 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.2.1 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.2.2 South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.2.3 South Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.2.4 South Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.2.5 South Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.3 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.1 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.2 UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.3.3 UAE: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.3.4 UAE: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.3.5 UAE: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.4.1 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.4.2 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.4.3 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.4.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.4.5 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5 South and Central America: Point-of-Care Molecular Diagnostics Market
11.5.1 Overview
11.5.2 South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.3 South and Central America: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.5.4 South and Central America: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.5.5 South and Central America: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.5.6 South and Central America: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.5.7 South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.5.7.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.2 Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.1.3 Brazil: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.1.4 Brazil: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.1.5 Brazil: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5.7.2 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.1 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.2 Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.2.3 Argentina: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.2.4 Argentina: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.2.5 Argentina: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5.7.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.1 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.2 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.3.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.3.4 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.3.5 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 Overview - Impact of COVID-19
12.2 Impact of COVID-19 on Point-of-Care Molecular Diagnostic Market
12.3 North America: Impact Assessment of COVID-19 Pandemic
12.4 Europe: Impact Assessment of COVID-19 Pandemic
12.5 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.6 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.7 South and Central America: Impact Assessment of COVID-19 Pandemic

13. Point-of-Care Molecular Diagnostics Market- Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview

14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 binx health, inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix
15.1 About The Publisher
15.2 Glossary of Terms

List of Tables
Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 5. US Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 7. US Point-of-Care Molecular Diagnostics Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 8. US Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product and Services -Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product and Services -Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 29. France: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 47. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 48. Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 49. China: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 50. China Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 51. China: Point-of-Care Molecular Diagnostics Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 52. China Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 54. Japan Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 55. Japan: Point-of-Care Molecular Diagnostics Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 56. Japan Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 57. India: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 58. India Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 59. India: Point-of-Care Molecular Diagnostics Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 60. India Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 61. Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 62. Australia Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 63. Australia: Point-of-Care Molecular Diagnostics Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 64. Australia Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea: Point-of-Care Molecular Diagnostics Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 68. South Korea Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services - Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 74. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 77. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 78. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 79. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 80. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 81. South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 82. South Africa: Point-of-Care Molecular Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
Table 83. South Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 84. South Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 85. UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 86. UAE: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 87. UAE: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 88. UAE: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 93. South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 97. Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 98. Brazil: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 101. Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 102. Argentina: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 109. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 110. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 111. Glossary of Terms, Point-of-Care Molecular Diagnostics Market


List of Figures
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. Point-of-Care Molecular Diagnostics Market Segmentation, By Region
Figure 3. Global Point-of-Care Molecular Diagnostics Market Overview
Figure 4. Assays and Kits Segment Held the Largest Share by Product and Services in Point-of-Care Molecular Diagnostics Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Point-of-Care Molecular Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Point-of-Care Molecular Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Global Point-of-Care Molecular Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
Figure 15. Global Point-of-Care Molecular Diagnostics Market - By Geography Forecast and Analysis - 2021- 2028
Figure 16. Market Positioning of Key Players in Global Point-of-Care Molecular Diagnostics Market
Figure 17. Point-of-Care Molecular Diagnostics Market, by Product and Services 2021 & 2028 (%)
Figure 18. Assays and Kits: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Instruments: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Services and Software: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)
Figure 22. PCR: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)
Figure 26. Infectious Disease: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Oncology: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Hematology: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Prenatal Testing: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Endocrinology: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)
Figure 33. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Point-of-Care Molecular Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 38. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 39. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 40. US: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. Canada: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. Mexico: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Europe: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 44. Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 46. UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 53. Asia Pacific: Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 54. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 55. China: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. Japan: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. India: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 58. Australia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 59. South Korea: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 60. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 61. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 62. Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 64. Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 65. South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. South and Central America: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 69. South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 71. Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 72. Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 74. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America
Figure 75. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Europe
Figure 76. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Asia-Pacific
Figure 77. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Middle East and Africa
Figure 78. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in South and Central America
Figure 79. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Enzo Biochem, Inc.
  • Abbott
  • binx health, Inc.
  • Meridian BioScience, Inc.
  • Biocartis
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc.
Note: Product cover images may vary from those shown